Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals

This study has been completed.
Information provided by:
Boehringer Ingelheim Identifier:
First received: May 2, 2002
Last updated: September 19, 2005
Last verified: September 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: October 2002
  Estimated Primary Completion Date: No date given